Literature DB >> 8608630

Antigen-specific immunotherapy of autoimmune disease: a commentary.

D C Wraith1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8608630      PMCID： PMC2200373          DOI： 10.1111/j.1365-2249.1996.tb08286.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  36 in total

1.  Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity.

Authors:  B Metzler; D C Wraith
Journal:  Int Immunol       Date:  1993-09       Impact factor: 4.823

2.  Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

Authors:  E R Kearney; K A Pape; D Y Loh; M K Jenkins
Journal:  Immunity       Date:  1994-07       Impact factor: 31.745

3.  Antigen presentation by macrophage-enriched cells from the mouse Peyer's patch.

Authors:  L K Richman; A S Graeff; W Strober
Journal:  Cell Immunol       Date:  1981-07-15       Impact factor: 4.868

4.  Inhibition of specific immune responses by feeding protein antigens.

Authors:  D G Hanson; N M Vaz; L C Maia; M M Hornbrook; J M Lynch; C A Roy
Journal:  Int Arch Allergy Appl Immunol       Date:  1977

Review 5.  Immunotherapy of autoimmune disease.

Authors:  A Cooke; D C Wraith
Journal:  Curr Opin Immunol       Date:  1993-12       Impact factor: 7.486

6.  Low avidity recognition of self-antigen by T cells permits escape from central tolerance.

Authors:  G Y Liu; P J Fairchild; R M Smith; J R Prowle; D Kioussis; D C Wraith
Journal:  Immunity       Date:  1995-10       Impact factor: 31.745

Review 7.  Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.

Authors:  H L Weiner; A Friedman; A Miller; S J Khoury; A al-Sabbagh; L Santos; M Sayegh; R B Nussenblatt; D E Trentham; D A Hafler
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis.

Authors:  A D Dick; Y F Cheng; J Liversidge; J V Forrester
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

9.  Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization.

Authors:  A G Lamont; M G Bruce; K C Watret; A Ferguson
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

10.  Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.

Authors:  Y Chen; V K Kuchroo; J Inobe; D A Hafler; H L Weiner
Journal:  Science       Date:  1994-08-26       Impact factor: 47.728
View more
  5 in total

1.  Immune response of the coeliac nasal mucosa to locally-instilled gliadin.

Authors:  P Torre; S Fusco; F Quaglia; M L La Rotonda; F Paparo; M Maglio; R Troncone; L Greco
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  Suppression of murine collagen-induced arthritis by nasal administration of collagen.

Authors:  L K Myers; J M Seyer; J M Stuart; A H Kang
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

3.  Complexities of applying nasal tolerance induction as a therapy for ongoing relapsing experimental autoimmune encephalomyelitis (EAE) in DA rats.

Authors:  X F Bai; H L Li; F D Shi; J Q Liu; B G Xiao; P H Van der Meide; H Link
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

4.  Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.

Authors:  L Y Xu; Y M Huang; J S Yang; P H Van Der Meide; H Link; B G Xiao
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

5.  Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.

Authors:  H L Li; J Q Liu; X F Bai; P H vn der Meide; H Link
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.